'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option
Clare O'Callaghan, Tracey Dryden, Amelia Hyatt, Joanne Brooker, Sue Burney, Addie C Wootten, Alan White, Mark Frydenberg, Declan Murphy, Scott Williams, Penelope Schofield
Psycho-Oncology | WILEY-BLACKWELL | Published : 2014
Awarded by Victorian Cancer Agency
The authors thank the men and partners who participated in the study and also Emily Habgood, Nicole Kinnane, and Dr Ilona Juraskova for their assistance. This study was funded by the Victorian Cancer Agency as part of The Cancer of Prostate Translational Research in Victoria (CAPTIV) programme, grant code TSP11_02. Assistant Professor Schofield holds an NHMRC career development fellowship (CDA level 2). The research was approved by Human Research and Ethics Committees at Peter MacCallum Cancer Centre, Cabrini Health, and Royal Melbourne Hospital, Melbourne, Australia. No parts of this manuscript have been published elsewhere.